The power to TRANSCEND

被引:7
作者
Ripley, Toni L. [1 ]
Harrison, Donald [1 ]
机构
[1] Univ Oklahoma, Coll Pharm, Oklahoma City, OK 73190 USA
关键词
D O I
10.1016/S0140-6736(08)61243-X
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
引用
收藏
页码:1128 / 1130
页数:3
相关论文
共 11 条
[1]
Braunwald E, 2004, NEW ENGL J MED, V351, P2058
[2]
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Dahlöf, B ;
Devereux, RB ;
Kjeldsen, SE ;
Julius, S ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
LANCET, 2002, 359 (9311) :995-1003
[3]
Fox KM, 2003, LANCET, V362, P782
[4]
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors:: the CHARM-Alternative trial [J].
Granger, CB ;
McMurray, JJV ;
Yusuf, S ;
Held, P ;
Michelson, EL ;
Olofsson, B ;
Östergren, J ;
Pfeffer, MA ;
Swedberg, K .
LANCET, 2003, 362 (9386) :772-776
[5]
Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure [J].
Jorde, UP ;
Ennezat, PV ;
Lisker, J ;
Suryadevara, V ;
Infeld, J ;
Cukon, S ;
Hammer, A ;
Sonnenblick, EH ;
Le Jemtel, TH .
CIRCULATION, 2000, 101 (08) :844-846
[6]
KAHN N, 2006, CMAJ, V174, P1737
[7]
Comparison of candesartan, enalapril, and their combination in congestive heart failure - Randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study - The RESOLVD pilot study investigators [J].
McKelvie, RS ;
Yusuf, S ;
Pericak, D ;
Avezum, A ;
Burns, RJ ;
Probstfield, J ;
Tsuyuki, RT ;
White, M ;
Rouleau, J ;
Latini, R ;
Maggioni, A ;
Young, J ;
Pogue, J .
CIRCULATION, 1999, 100 (10) :1056-1064
[8]
RETRACTED: Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study (Retracted Article) [J].
Mochizuki, Seibu ;
Dahloef, Bjorn ;
Shimizu, Mitsuyuki ;
Ikewaki, Katsunori ;
Yoshikawa, Makoto ;
Taniguchi, Ikuo ;
Ohta, Makoto ;
Yamada, Taku ;
Ogawa, Kazuhiko ;
Kanae, Kiyoshi ;
Kawai, Makoto ;
Seki, Shingo ;
Okazaki, Fumiko ;
Taniguchi, Masayuki ;
Yoshida, Satoru ;
Tajima, Naoko .
LANCET, 2007, 369 (9571) :1431-1439
[9]
*TRANSCEND INV, 2008, LANCET 0831
[10]
Yusuf S, 2000, NEW ENGL J MED, V342, P145